Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

A kidney drug taken by millions of Americans has been pulled from the shelves after it was found to be contaminated with a cancer-causing ingredient. In total, 331,590 bottles of cinacalcet ...

Concomitant use of cinacalcet and drugs that alter the activity of cinacalcet-metabolizing enzymes might necessitate alteration of cinacalcet dose. When metabolism of cinacalcet by the cytochrome ...